Authors: Adler, Michael; Spengler, Mark

Source: Current Pharmaceutical Analysis, Volume 5, Number 4, November 2009 , pp. 390-407(18)

Publisher: Bentham Science Publishers

Abstract:

The combination of flexible and robust immunoassay technology with the sensitivity of DNA as a signal amplification template is realized in Immuno-PCR (“IPCR”). Classical ELISA is converted to IPCR by exchange of antibodyenzyme detection conjugates with antibody-DNA conjugates. The value of ultra-sensitive analytics deriving from this for pharmaceutical R&D is threefold: (I) Deeper understanding of biomolecular interactions for the development of new compounds. (II) Monitoring of compounds at very low concentrations in toxicokinetic and pharmacokinetic clinical studies. (III.) Control of compound functionality and therapeutic effects by surveillance of characteristic biomarkers and/or immunogenicity reactions. This review summarizes background information about general selection of IPCR targets, actual standard assay procedures and work with biological matrices. Quantitative real-time detection as well as optimized reagents and protocols revealed a typically 100-10,000-fold increase in sensitivity and a broad dynamic range compared to ELISA. Case studies are discussed for (I) the analysis of biomolecular interaction with proximity ligation technologies and IPCR, (II) pharmacokinetic studies of novel drugs with validation data for assay precision and recovery and (III) biomarker profiling, including cytokine multiplex assays and polyplex trace analysis in extremely small sample volumes. In a survey of results from recent innovations, the potential of this emerging field of applications is evaluated for novel pathways in study design and analytics.

Keywords: Immuno-PCR; ELISA; Sensitivity; Biomarker analysis; Pharmacokinetics; polyplex

Document Type: Research article

Publication date: 2009-11-01

More about this publication?

• Current Pharmaceutical Analysis publishes authoritative reviews, written by experts in the field on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Related content

• In this: publication
• By this: publisher
• In this Subject: Chemistry (General)
• By this author: Adler, Michael ;  Spengler, Mark

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers